This study is testing a new treatment, called BMS-986393, for people with a tough type of cancer called Multiple Myeloma (MM). MM affects the bone marrow, where blood cells are made. The study checks if BMS-986393 works better or is safer than the usual treatments. Patients must have received other treatments before and still have the disease. They need to be in good health otherwise, and their MM should not affect their brain or need emergency care.
Key Points:
- The study compares a new drug to standard treatments for adults with certain types of MM.
- Participants must have previously tried other MM treatments and still have the disease.
- Participants should not have brain involvement or need urgent care for MM.
How understandable was the trial content above?
Hard to understand
Easy to understand